The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for R Kaur


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
29
The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor.EBI
Glaxosmithkline
14
Structure and ligand based design for identification of highly potent molecules against 5-LOX.EBI
Guru Nanak Dev University
4
The development of thymol-isatin hybrids as broad-spectrum antibacterial agents with potent anti-MRSA activity.EBI
Guru Nanak Dev University
5
Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.EBI
Punjabi University
124
Clubbed thiazoles by MAOS: a novel approach to cyclin-dependent kinase 5/p25 inhibitors as a potential treatment for Alzheimer's disease.EBI
Dr. Reddys Laboratories
33
Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus.EBI
University Institute of Pharmaceutical Sciences
1
Synthetic and medicinal perspective of quinolines as antiviral agents.EBI
Indo-Soviet Friendship College of Pharmacy (ISFCP)
1
Rationally designed TNF-α inhibitors: Identification of promising cytotoxic agents.EBI
Guru Nanak Dev University
4
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.EBI
Glaxosmithkline
4
Recent synthetic and medicinal perspectives of tryptanthrin.EBI
Indo-Soviet Friendship College of Pharmacy (Isfcp)
12
Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.EBI
Indo-Soviet Friendship College of Pharmacy (Isfcp)